# Introducing the "opacity" for IMPT planning: can it improve robustness and quality of plans?

## TL;DR

This paper introduces an 'opacity' parameter in IMPT planning to enhance plan quality and robustness, especially in cases with metallic implants or variable organ densities, by pre-optimizing beam fluences intersecting critical structures.

## Contribution

The novel 'opacity' feature modifies pencil beam fluences based on organ proximity, improving IMPT plan accuracy and stability in challenging clinical scenarios.

## Key findings

- Opacity improves dose distribution robustness.
- Enhanced plan quality with metallic prostheses.
- Better handling of density variations in organs.

## Abstract

Intensity modulated proton therapy (IMPT) provides highly conformal dose distributions through the application of multiple, angularly spaced fields, each applying an ad-hoc pattern of spatially varying particle fluences. In particular, Bragg peaks are simultaneously optimized for all the fields. Once the number and the direction of the fields are set, the dose distribution of the IMPT plan is determined by the dose constraints assigned to specific organs-at-risk (OARs) surrounding the tumour. In this work, we introduce a new feature for the OARs, called "opacity", aimed at improving the quality and the robustness of IMPT plans, by modifying, in the pre-optimization stage, the fluence of the pencil beams, that intersect those structures. The proposed IMPT planning strategy is addressed to those clinical cases, where metallic prothesis or fast density-varying organs can compromise the stability of the dose distribution. We show how the usage of this additional parameter can lead to more accurate IMPT plans with respect to the situation in which only dose constraints are adopted.